Tying early vitamin supplementation to asthma and allergy

Roflumilast cream 0.05% is being studied for mild-to-moderate AD in infants aged 3 months to under 2 years in a new phase 2 trial.

The final episode in our podcast series on atypical anorexia discusses fat bias in health care and its impact on diagnosis and when pushback against diagnosis happens.

The FDA has extended the review of ruxolitinib for atopic dermatitis in children 2 to 11 years to September 2025 to evaluate new CMC data.

Dr. Erin Harrop discusses the necessity of understanding that eating disorders do not all look the same in every patient and how a multidisciplinary approach could be an effective way to diagnose and manage anorexia nervosa that is atypical.

Research presented at NUTRITION 2025 shows that fathers with improved adolescent diets are more likely to model and monitor healthy eating for their children.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.